Matthew Higgins

Research

Pharmaceutical economics

Corporate strategy

Economics of innovation

Applied econometrics

Education

PhD, Emory University

Biography

Dr. Matthew J. Higgins joined the Strategy & Innovatiom faculty in 2005. His research interests center primarily on firm responses to productivity changes (and challenges) and the performance implications of these decisions. This includes understanding the interrelationship between internal R&D and the use of external technology markets through acquisitions, alliances, licensing, and corporate venture capital. Utilizing a novel risk model, this also includes whether firms are dynamically optimizing their R&D portfolios. Focusing on the external environment, Dr. Higgins is interested in the impact regulation has on innovation and productivity. Most of Dr. Higgins'' research has been conducted within the context of the pharmaceutical industry and has been accepted for publication in a diverse range of leading journals including Science, RAND Journal of Economics, Journal of Financial Economics, Review of Economics and Statistics and Strategic Management Journal. 

Dr. Higgins is the receipt of a numerous teaching awards from the MBA and Executive MBA programs. He was also the recipient of a National Science Foundation''s Integrative Graduate Education and Research Traineeship Fellowship (IGERT). In 2012, he was nominated and appointed as a Faculty Research Fellow to the National Bureau of Economic Research (NBER) program on Productivity, Innovation and Entrepreneurship. He is currently a Research Associate with NBER. To date his research has received over $3 million in funding and support from organization such as the Georgia Research Alliance, Kauffman Foundation, the National Institutes of Health (NIH), National Science Foundation (NSF), Pfizer and IMS Health, Inc.

Research papers may be accessed at: http://ssrn.com/author=85850

Google Scholar: http://scholar.google.com/citations?user=4XHZ6-UAAAAJ

NBER: http://www.nber.org/people/matthew_higgins